Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension

PURPOSE: To evaluate the additive intraocular pressure–lowering effect of twice-daily brinzolamide 1%/brimonidine 0.2% fixed-dose combination (BBFC) as an adjunct to a prostaglandin analog (PGA) in patients with open-angle glaucoma or ocular hypertension insufficiently controlled with PGA monotherap...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Eur J Ophthalmol
Hoofdauteurs: Topouzis, Fotis, Goldberg, Ivan, Bell, Katharina, Tatham, Andrew J, Ridolfi, Antonia, Hubatsch, Douglas, Nicolela, Marcelo, Denis, Phillipe, Lerner, S Fabian
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2019
Onderwerpen:
Original Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859663/
https://ncbi.nlm.nih.gov/pubmed/31595773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1120672119878044
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items